journal
MENU ▼
Read by QxMD icon Read
search

Pediatric Hematology and Oncology

journal
https://www.readbyqxmd.com/read/28537810/incidence-and-characteristics-of-venous-thrombotic-events-in-pediatric-cancer-patients-a-20-year-experience-in-the-maritimes-canada
#1
Zeina Asyyed, Tamara MacDonald, Carol Digout, Ketan Kulkarni
OBJECTIVE: Venous thrombotic events (VTE) are a well-recognized complication in pediatric cancer patients. Population-based data on the incidence and characteristics of VTE in all pediatric cancer patients are limited. This information is crucial to identify patients at high risk and design targeted interventions accordingly. The present study was designed to determine the incidence and characteristics of VTE in the pediatric oncology population. PARTICIPANTS: We conducted a retrospective, population-based, cohort study of patients treated in the Maritimes, Canada between 1995 and 2015...
May 24, 2017: Pediatric Hematology and Oncology
https://www.readbyqxmd.com/read/28537785/a-practical-guide-to-the-use-of-eltrombopag-in-children-with-chronic-immune-thrombocytopenia
#2
John D Grainger, Sharon Thind
INTRODUCTION: Pediatric immune thrombocytopenia (ITP) may be associated with significant burden on children and their parents/caregivers. Thrombopoietin (TPO) receptor agonists (RAs) have been used to treat adult patients with chronic ITP (cITP) for nearly a decade and following pediatric studies Eltrombopag has been recently approved for pediatric cITP in the United States and Europe. TPO-RA s may help reduce the risk of bleeding and the need for conventional ITP therapies. REVIEW: In this review, the clinical data demonstrating the efficacy and safety of TPO-RAs in pediatric ITP are evaluated, key recommendations regarding safe administration of eltrombopag are provided, and potential future directions in management of pediatric ITP are discussed...
May 24, 2017: Pediatric Hematology and Oncology
https://www.readbyqxmd.com/read/28532265/encephaloduroarteriosynangiosis-edas-in-young-patients-with-cerebrovascular-complications-of-sickle-cell-disease-single-institution-experience
#3
Michael Winstead, Peter P Sun, Kenneth Martin, Janice Earl, Lynne Neumayr, Carolyn Hoppe, Elliott Vichinsky
Moyamoya syndrome occurs in sickle cell disease (SCD) as a secondary complication of large-artery stenosis. Moyamoya increases the risk of stroke, but its optimal management in SCD is not established.  Encephaloduroarteriosynangiosis (EDAS) is a neurosurgical revascularization procedure for moyamoya whose use has been reported in SCD patients. We report the outcomes of 11 patients with SCD systematically evaluated for EDAS by a multidisciplinary team and compare the rate of stroke in patients who received EDAS to those who did not...
May 22, 2017: Pediatric Hematology and Oncology
https://www.readbyqxmd.com/read/28410059/corrigendum
#4
(no author information available yet)
No abstract text is available yet for this article.
February 2017: Pediatric Hematology and Oncology
https://www.readbyqxmd.com/read/28287340/false-positive-direct-antiglobulin-test-in-hematologic-malignancies
#5
Zafter Bicakci
No abstract text is available yet for this article.
February 2017: Pediatric Hematology and Oncology
https://www.readbyqxmd.com/read/28287336/current-outlook-of-childhood-cancer-epidemiology-in-a-middle-income-country-under-a-public-health-insurance-program
#6
Roberto Rivera-Luna, Liliana Velasco-Hidalgo, Marta Zapata-Tarrés, Rocío Cárdenas-Cardos, Marco R Aguilar-Ortiz
In Mexico, childhood cancer (0-18 years) is treated in a multidisciplinary way while providing care for more than half of the affected children through a public medical insurance. This insurance is given to all children who do not have any health care coverage in Mexico. This program is offered to the poorest of all Mexicans. All the children with this disease are submitted to pathology diagnosis and treatment according to national treatment protocols from 57 accredited medical institutions. From 2007 to 2015, a total of 24,039 children with cancer have been registered; the male gender predominates by 55%...
February 2017: Pediatric Hematology and Oncology
https://www.readbyqxmd.com/read/28287332/association-of-energy-intake-and-expenditure-with-obesity-a-cross-sectional-study-of-150-pediatric-patients-following-treatment-for-leukemia
#7
Richa Srivastava, Atul Batra, Deepa Dhawan, Sameer Bakhshi
Increased obesity in leukemia survivors has been attributed to chemotherapy and radiation. Data on total energy intake (TEI) and total energy expenditure (TEE) are lacking in obese childhood leukemia patients after completion of therapy from India. We conducted a cross-sectional study in pediatric acute leukemia patients after completion of therapy wherein energy intake was assessed by 24-hour recall method. TEE was calculated using Harris-Benedict equation, by assessing the physical activity level using Physical Activity Questionnaire for children and basal metabolic rate by World Health Organization equation...
February 2017: Pediatric Hematology and Oncology
https://www.readbyqxmd.com/read/28287326/treatment-delay-and-the-risk-of-relapse-in-pediatric-acute-lymphoblastic-leukemia
#8
Amelia Yeoh, Anna Collins, Kahlia Fox, Sarah Shields, Petra Ritchie, Maria Kirby, Tamas Revesz
Delays or interruptions in chemotherapy due to toxicity such as neutropenia or severe infections are common in the treatment of pediatric acute lymphoblastic leukemia (ALL). Based on the reports of worse outcomes in children with poorer compliance with therapy, there has been concern that toxicity-induced therapy interruptions could also compromise treatment outcome. In a retrospective study of treatment delays in our hospital between 2003 and 2013, the case notes of 141 patients were reviewed. The cumulative lengths of delays during the whole length of chemotherapy, during the intensive phase of treatment, and during maintenance treatment were analyzed...
February 2017: Pediatric Hematology and Oncology
https://www.readbyqxmd.com/read/28276750/red-blood-cell-distribution-width-is-not-a-reliable-biomarker-for-low-iron-stores-in-children-with-cystic-fibrosis
#9
M D Akkermans, L Uijterschout, M Nuijsink, D M Hendriks, J B van Goudoever, F Brus
Low iron stores in children, absolute iron deficiency (AID), can lead to impaired neurodevelopment and requires iron therapy. In the presence of infection/inflammation, like in cystic fibrosis (CF), serum ferritin (SF) is not a reliable biomarker for AID. Red blood cell distribution width (RDW) is a promising alternative reported not to be influenced by infection in healthy children. Currently, there are no data on the diagnostic capacity of RDW to detect AID in pediatric CF patients. This was a prospective observational study that investigated iron status biomarkers in 53 Dutch pediatric CF patients...
February 2017: Pediatric Hematology and Oncology
https://www.readbyqxmd.com/read/28085536/liver-transplantation-as-a-potentially-lifesaving-measure-in-neuroblastoma-stage-4s
#10
Till Holsten, Tobias Schuster, Enke Grabhorn, Barbara Hero, Michael C Frühwald
Neuroblastoma (NBL) stage 4s is an incompletely understood phenomenon with variable clinical course. While the majority of patients may undergo spontaneous regression and achieve complete resolution without intensive therapy, a small proportion is at increased risk of developing secondary complications. One such situation is liver insufficiency due to diffuse metastases. We report a patient suffering from NBL 4S who required double lifesaving liver transplantation. Abdominal and respiratory complications due to hepatomegaly are crucial determinants for treatment intensity and duration in 4S NBL [1,2] ...
February 2017: Pediatric Hematology and Oncology
https://www.readbyqxmd.com/read/28085529/neutropenic-acute-acalculous-cholecystitis-aac-in-a-12-year-old-boy-with-t-acute-lymphoblastic-leukemia-successfully-managed-with-conservative-treatment
#11
Aldo Naselli, Hugh Bishop, Shonagh Walker, Adilia Warris
Acute acalculous cholecystitis (AAC) is an inflammation of the gallbladder without the presence of gallstones. In children with malignancies or chemotherapy-induced neutropenia, AAC is very rare. Clinical diagnosis of AAC remains difficult in this patient population but an early recognition followed by an appropriate intervention may confer a benefit. Only three pediatric patients with underlying hematological malignancies whose clinical treatment course was complicated by the development of AAC have been described...
February 2017: Pediatric Hematology and Oncology
https://www.readbyqxmd.com/read/28067581/understanding-adherence-to-treatment-and-physical-activity-in-children-with-hemophilia-the-role-of-psychosocial-factors
#12
Sarah Bérubé, Audrey Cloutier-Bergeron, Claudine Amesse, Serge Sultan
The objective of this study was to identify psychosocial factors to explain intentions of children and adolescents with hemophilia to adhere to recommendations for self-care. Twenty-four patients with hemophilia A and B, aged 6-18 years old, and their parents, completed a survey. Measures assessed factors from the theory of planned behavior, physical activity, and medical treatment adherence. The results indicate that past behaviors, attitudes, and subjective norms explained a large proportion of the intention to engage in future nonrecommended physical activity...
February 2017: Pediatric Hematology and Oncology
https://www.readbyqxmd.com/read/27960647/proton-pump-inhibitors-use-suppresses-iron-absorption-in-congenital-dyserythropoietic-anemia
#13
Hanna Shalev, Abed Abu Quider, Miriam Ben Harosh, Josef Kapelushnik
Congenital dyserythropoietic anemia type I (CDA I) is associated, as other anemic noninflammatory states, with ineffective erythropoiesis and increased iron absorption, which may lead to complication of iron overload. The latter complication requires iron-chelating therapy, which may be associated with adverse effects and toxicity. Gastric acid production is known to be an important factor that facilitates non-heme iron absorption. The purpose of this study was to examine whether treatment with proton pump inhibitors (PPIs) can decrease iron absorption in patients with CDA I...
October 2016: Pediatric Hematology and Oncology
https://www.readbyqxmd.com/read/27960646/varicella-in-pediatric-oncology-patients-in-the-post-vaccine-era-analysis-of-routine-hospital-data-from-bavaria-germany-2005-2011
#14
Andrea Streng, Verena Wiegering, Johannes G Liese
Varicella in oncology patients can result in serious complications. We analyzed trends in hospitalization rates and characteristics of pediatric oncology and non-oncology patients hospitalized with varicella during the first 7 years after introduction of routine varicella vaccination. Our data included children <17 years of age with an International Classification of Diseases and Related Health Problems, 10th Revision (ICD-10) main or secondary discharge diagnosis of varicella identified by annual database queries in 22-29 pediatric hospitals in Bavaria (Germany) in 2005-2011...
October 2016: Pediatric Hematology and Oncology
https://www.readbyqxmd.com/read/27960645/combined-therapy-in-children-and-adolescents-with-classical-hodgkin-s-lymphoma-a-report-from-the-sfce-on-mdh-03-national-guidelines
#15
E Seror, J Donadieu, H Pacquement, S Abbou, A Lambilliotte, M Schell, C Curtillet, V Gandemer, M Pasquet, N Aladjidi, P Lutz, C Schmitt, A Deville, O Minckes, J P Vanier, C Armari-Alla, C Thomas, S Gorde-Grosjean, F Millot, P Blouin, N Garnier, C Coze, C Devoldere, Y Reguerre, S Helfre, L Claude, J Clavel, O Oberlin, J Landman-Parker, T Leblanc
Hodgkin's lymphoma (HL) in children and adolescents is highly curable, but children are at risk of long-term toxicity. The MDH-03 guidelines were established in order to decrease the burden of treatment in good-responder patients, and this report should be considered a step toward further optimization of treatment within large collaborative trials. We report the therapy and long-term outcomes of 417 children and adolescents treated according to the national guidelines, which were applied between 2003 and 2007 in France...
October 2016: Pediatric Hematology and Oncology
https://www.readbyqxmd.com/read/27960644/cutaneous-diffuse-large-b-cell-lymphoma-in-an-infant
#16
Anirban Das, Deepak Bansal, Debajyoti Chatterjee, Radhika Srinivasan, Nandita Kakkar
No abstract text is available yet for this article.
October 2016: Pediatric Hematology and Oncology
https://www.readbyqxmd.com/read/27960642/the-role-of-cdkn2a-b-deletions-in-pediatric-acute-lymphoblastic-leukemia
#17
P Carrasco Salas, L Fernández, M Vela, D Bueno, B González, J Valentín, P Lapunzina, A Pérez-Martínez
The CDKN2A/B genes in the 9p21 chromosomal region are frequently involved in human cancer, including pediatric acute lymphoblastic leukemia (ALL). These genes encode 3 proteins that belong to the RB1 and TP53 pathways and act as tumor suppressors by regulating the G1/S checkpoint of the cell cycle. The prognostic value of deletions in the CDKN2A/B locus in ALL is controversial in part due to the limitations of the methodologies used. Further studies with advanced technologies are needed for elucidation. Future studies would also highlight whether CDK4/CDK6 selective inhibitors might be useful therapies for children with these genetic aberrations...
October 2016: Pediatric Hematology and Oncology
https://www.readbyqxmd.com/read/27922762/nonchemotherapy-drug-induced-agranulocytosis-in-children-detected-by-a-prospective-pharmacovigilance-program
#18
Nicolás Medrano-Casique, Hoi Y Tong, Alberto M Borobia, Antonio J Carcas, Jesús Frías, Elena Ramírez
OBJECTIVES: A prospective evaluation of nonchemotherapy drug-induced agranulocytosis (DIA) cases, which are infrequent in the pediatric population. We characterize agranulocytosis cases and assess lab test differences between drug- and nondrug-induced agranulocytosis. METHODS: Through our Prospective Pharmacovigilance Program from Laboratory Signals at Hospital we detected pediatric agranulocytosis cases from July 2007 to December 2010. This program estimates the incidence, drug causality, clinical features, outcomes of DIA pediatric cases, and assesses laboratory differences with respect to non-DIA...
October 2016: Pediatric Hematology and Oncology
https://www.readbyqxmd.com/read/27922758/the-feasibility-of-implementing-a-communication-skills-training-course-in-pediatric-hematology-oncology-fellowship
#19
Lauren Weintraub, Lisa Figueiredo, Michael Roth, Adam Levy
Communication skills are a competency highlighted by the Accreditation Council on Graduate Medical Education; yet, little is known about the frequency with which trainees receive formal training or what programs are willing to invest. We sought to answer this question and designed a program to address identified barriers. We surveyed pediatric fellowship program directors from all disciplines and, separately, pediatric hematology/oncology fellowship program directors to determine current use of formal communication skills training...
October 2016: Pediatric Hematology and Oncology
https://www.readbyqxmd.com/read/27922757/hemophagocytic-lymphohistiocytosis-triggered-by-gaucher-disease-in-a-preterm-neonate
#20
Simone Schüller, Andishe Attarbaschi, Angelika Berger, Caroline Hutter, Katrin Klebermass-Schrehof, Manuel Steiner
OBJECTIVE: To present the diagnostic workup in an extremely low birth weight infant patient with signs of both sepsis and hemophagocytosis. PARTICIPANTS: A preterm infant presented with clinical and laboratory signs of early-onset sepsis including hepatosplenomegaly, thrombocytopenia, direct hyperbilirubinemia, and elevated liver enzymes. METHODS: Despite extensive septic workup, no underlying infection was detected. Additional hyperferritinemia and other elevated inflammatory parameters raised the suspicion of a primary or secondary hemophagocytic lymphohistiocytosis (HLH)...
October 2016: Pediatric Hematology and Oncology
journal
journal
29411
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"